BioStock Life Science Spring Summit, June 8-9, 2022
The BioStock Life Science Spring Summit is our first flagship event of 2022! Over the course of two days in early June, around 30...
BioStock Investor Meeting 16 March
Today, March 16 at 10am, BioStock will host the first digital BioStock Investor Meeting of the year, where representatives of a variety of life...
BioStock Investor Meeting, September 14
On September 14, we will arrange the next BioStock Investor Meeting, where life science companies from a number of therapeutic areas present their business...
BioStock Investor Meeting, March 16
On March 16, we arranged the first virtual BioStock Investor Meeting of 2022. The event gave representatives from a number of life science companies...
Join us for the BioStock Life Science Summit on October 20...
The BioStock Life Science Summit continues to connect life science innovators with investors focused on the Nordic life science scene. Join us during October...
BioStock Live: World Sepsis Day Seminar with Aptahem
September 13 is #WorldSepsisDay, and this year marks the 10th anniversary of the occasion. Events in all parts of the world are taking place to...
BLSS videos: tips for raising capital within Nordic life science
BioStock Life Science Summit brought together four of the top corporate finance firms in the Nordics to have a fruitful discussion about raising capital...
BLSS videos: the keys to big pharma partnerships
BioStock Life Science Summit was a great opportunity for small pharma and medtech companies to meet and discuss potential partnership deals with Big Pharma....
CLS sets the direction for 2021 with clinical and commercial focus...
The past year has seen several important steps forward for medtech company Clinical Laserthermia Systems, with expanded collaborations with the University Hospital Magdeburg and...
Regulatory approval and up-listing for Cyxone
Activity is high in Cyxone. The biotechnology company recently received approval to start a phase II study in Poland with Rabeximod in patients suffering...
